Healthcare provider profile · identity verified

John Rogers, MD

Internal Medicine · MATTOON, IL · NPI 1023086295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	699	133
Metoprolol Succinate	Metoprolol Succinate	679	123
Levothyroxine Sodium	Levothyroxine Sodium	612	96
Potassium Chloride	Potassium Chloride	526	85
Omeprazole	Omeprazole	465	92
Amlodipine Besylate	Amlodipine Besylate	461	102
Furosemide	Furosemide	433	83
Losartan Potassium	Losartan Potassium	405	81
Lisinopril	Lisinopril	372	83
Rosuvastatin Calcium	Rosuvastatin Calcium	344	62
Pantoprazole Sodium	Pantoprazole Sodium	340	65
Hydrochlorothiazide	Hydrochlorothiazide	325	69
Eliquis	Apixaban	304	40
Gabapentin	Gabapentin	269	58
Escitalopram Oxalate	Escitalopram Oxalate	206	31
Clopidogrel	Clopidogrel Bisulfate	203	31
Metformin Hcl	Metformin Hcl	202	39
Metoprolol Tartrate	Metoprolol Tartrate	165	28
Montelukast Sodium	Montelukast Sodium	163	32
Xarelto	Rivaroxaban	155	14
Simvastatin	Simvastatin	145	32
Donepezil Hcl	Donepezil Hcl	138	21
Tamsulosin Hcl	Tamsulosin Hcl	133	25
Buspirone Hcl	Buspirone Hcl	125	22
Pravastatin Sodium	Pravastatin Sodium	124	28
Duloxetine Hcl	Duloxetine Hcl	121	16
Jardiance	Empagliflozin	120	22
Allopurinol	Allopurinol	109	24
Glimepiride	Glimepiride	102	24
Memantine Hcl	Memantine Hcl	102	13
Alendronate Sodium	Alendronate Sodium	101	20
Fluticasone Propionate	Fluticasone Propionate	99	29
Ezetimibe	Ezetimibe	94	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	94	16
Sertraline Hcl	Sertraline Hcl	94	16
Carvedilol	Carvedilol	92	18
Trazodone Hcl	Trazodone Hcl	92	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	22
Warfarin Sodium	Warfarin Sodium	91	20
Hydralazine Hcl	Hydralazine Hcl	87	18
Ropinirole Hcl	Ropinirole Hcl	86	13
Famotidine	Famotidine	84	11
Ozempic	Semaglutide	82	13
Januvia	Sitagliptin Phosphate	78	17
Doxazosin Mesylate	Doxazosin Mesylate	75	12
Fluoxetine Hcl	Fluoxetine Hcl	63	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	61	14
Citalopram Hbr	Citalopram Hydrobromide	57	12
Oxybutynin Chloride Er	Oxybutynin Chloride	56	12
Finasteride	Finasteride	54	suppressed
Metformin Hcl Er	Metformin Hcl	51	12
Amiodarone Hcl	Amiodarone Hcl	50	suppressed
Atenolol	Atenolol	48	13
Levetiracetam	Levetiracetam	48	suppressed
Spironolactone	Spironolactone	48	15
Glipizide	Glipizide	47	suppressed
Breo Ellipta	Fluticasone/Vilanterol	46	suppressed
Glipizide Er	Glipizide	41	14
Olanzapine	Olanzapine	41	suppressed
Bupropion Hcl Sr	Bupropion Hcl	40	suppressed
Tramadol Hcl	Tramadol Hcl	39	17
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Primidone	Primidone	35	suppressed
Lovastatin	Lovastatin	34	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	34	suppressed
Prednisone	Prednisone	34	27
Trulicity	Dulaglutide	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	22
Baclofen	Baclofen	33	suppressed
Enalapril Maleate	Enalapril Maleate	33	suppressed
Alprazolam	Alprazolam	32	12
Meclizine Hcl	Meclizine Hcl	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	17
Risperidone	Risperidone	30	suppressed
Lorazepam	Lorazepam	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	11
Midodrine Hcl	Midodrine Hcl	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Ranolazine Er	Ranolazine	27	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	21
Mirtazapine	Mirtazapine	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Ventolin Hfa	Albuterol Sulfate	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Digoxin	Digoxin	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Dilantin	Phenytoin Sodium Extended	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Semglee (Yfgn)	Insulin Glargine-Yfgn	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Fosinopril Sodium	Fosinopril Sodium	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Anastrozole	Anastrozole	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Megestrol Acetate	Megestrol Acetate	16	suppressed
Metolazone	Metolazone	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Briviact	Brivaracetam	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Gemtesa	Vibegron	15	suppressed
Insulin Lispro	Insulin Lispro	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Levofloxacin	Levofloxacin	15	13
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Cefdinir	Cefdinir	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	suppressed
Torsemide	Torsemide	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Methimazole	Methimazole	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Rytary	Carbidopa/Levodopa	12	suppressed
Teriflunomide	Teriflunomide	12	suppressed
Timolol Maleate	Timolol Maleate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error